• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Telomere fusions in early human breast carcinoma.端粒融合在早期人类乳腺癌中。
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14098-103. doi: 10.1073/pnas.1120062109. Epub 2012 Aug 13.
2
Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.端粒介导的基因组不稳定与乳腺癌的临床病理参数
Genes Chromosomes Cancer. 2008 Dec;47(12):1098-109. doi: 10.1002/gcc.20608.
3
Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.乳腺癌患者组织中端粒相对长度模式与端粒酶逆转录酶基因表达相关。
Clin Breast Cancer. 2019 Feb;19(1):27-34. doi: 10.1016/j.clbc.2018.07.021. Epub 2018 Aug 22.
4
Onset of Telomere Dysfunction and Fusions in Human Ovarian Carcinoma.端粒功能障碍和融合在人卵巢癌中的发生。
Cells. 2019 May 4;8(5):414. doi: 10.3390/cells8050414.
5
Genomic instability demonstrates similarity between DCIS and invasive carcinomas.基因组不稳定性表明导管原位癌和浸润性癌之间存在相似性。
Breast Cancer Res Treat. 2009 Sep;117(1):17-24. doi: 10.1007/s10549-008-0165-4. Epub 2008 Sep 11.
6
The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.散发性结肠癌中端粒融合的存在与疾病分期、TP53/KRAS突变状态、平均端粒长度及端粒酶活性无关。
Neoplasia. 2014 Oct 23;16(10):814-23. doi: 10.1016/j.neo.2014.08.009. eCollection 2014 Oct.
7
Telomerase activity in normal and neoplastic breast.正常乳腺与肿瘤乳腺中的端粒酶活性
Clin Cancer Res. 1997 Apr;3(4):627-31.
8
Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.白花丹素触发人乳腺癌细胞的 DNA 损伤反应、端粒功能障碍和基因组不稳定性。
Biomed Pharmacother. 2016 Aug;82:256-68. doi: 10.1016/j.biopha.2016.05.007. Epub 2016 May 14.
9
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.端粒结合蛋白表达水平与乳腺癌中端粒长度的协调调控。
Cancer Med. 2012 Oct;1(2):165-75. doi: 10.1002/cam4.14. Epub 2012 Jul 24.
10
Breast tumor copy number aberration phenotypes and genomic instability.乳腺肿瘤拷贝数畸变表型与基因组不稳定性。
BMC Cancer. 2006 Apr 18;6:96. doi: 10.1186/1471-2407-6-96.

引用本文的文献

1
Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology.概念与关注:辅助生殖技术中乳腺癌风险综述
Int J Biol Sci. 2025 Mar 24;21(6):2647-2671. doi: 10.7150/ijbs.105357. eCollection 2025.
2
The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss.分子和细胞衰老途径在与年龄相关的听力损失中的作用。
Int J Mol Sci. 2024 Sep 7;25(17):9705. doi: 10.3390/ijms25179705.
3
The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients.ALT 通路会产生端粒融合,这些融合可以在癌症患者的血液中被检测到。
Nat Commun. 2024 Jan 2;15(1):82. doi: 10.1038/s41467-023-44287-8.
4
Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.驱动蛋白家族成员C1(KIFC1/HSET):早期乳腺肿瘤发生及高危病变进展的潜在可作用生物标志物
J Pers Med. 2021 Dec 14;11(12):1361. doi: 10.3390/jpm11121361.
5
Mechanisms and Regulation of Cellular Senescence.细胞衰老的机制与调控。
Int J Mol Sci. 2021 Dec 6;22(23):13173. doi: 10.3390/ijms222313173.
6
Regulation of Gene Expression by Telomere Position Effect.端粒位置效应调控基因表达。
Int J Mol Sci. 2021 Nov 26;22(23):12807. doi: 10.3390/ijms222312807.
7
Progesterone and Breast Cancer.孕激素与乳腺癌。
Endocr Rev. 2020 Apr 1;41(2):320-44. doi: 10.1210/endrev/bnz001.
8
Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.干细胞、永生与乳腺癌转移特性的演变:端粒维持机制与转移进化
J Cancer Metastasis Treat. 2019;5. doi: 10.20517/2394-4722.2019.15. Epub 2019 May 6.
9
Onset of Telomere Dysfunction and Fusions in Human Ovarian Carcinoma.端粒功能障碍和融合在人卵巢癌中的发生。
Cells. 2019 May 4;8(5):414. doi: 10.3390/cells8050414.
10
Ongoing human chromosome end extension revealed by analysis of BioNano and nanopore data.生物纳米和纳米孔数据分析揭示的人类染色体端延伸过程。
Sci Rep. 2018 Nov 9;8(1):16616. doi: 10.1038/s41598-018-34774-0.

本文引用的文献

1
Telomerase regulation.端粒酶调控。
Mutat Res. 2012 Feb 1;730(1-2):20-7. doi: 10.1016/j.mrfmmm.2011.10.003. Epub 2011 Oct 18.
2
Double-strand break end resection and repair pathway choice.双链断裂末端切除和修复途径选择。
Annu Rev Genet. 2011;45:247-71. doi: 10.1146/annurev-genet-110410-132435. Epub 2011 Sep 12.
3
Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.Geminin 过表达可阻止拓扑异构酶 IIα 染色体的解连环,导致人乳腺上皮细胞非整倍体。
Breast Cancer Res. 2011 May 19;13(3):R53. doi: 10.1186/bcr2884.
4
Telomeres in cancer and ageing.端粒与癌症和衰老。
Philos Trans R Soc Lond B Biol Sci. 2011 Jan 12;366(1561):76-84. doi: 10.1098/rstb.2010.0291.
5
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.端粒功能障碍和融合在慢性淋巴细胞白血病进展过程中的作用:端粒危机的证据。
Blood. 2010 Sep 16;116(11):1899-907. doi: 10.1182/blood-2010-02-272104. Epub 2010 Jun 10.
6
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.非同源 DNA 末端连接途径修复双链 DNA 断裂的机制。
Annu Rev Biochem. 2010;79:181-211. doi: 10.1146/annurev.biochem.052308.093131.
7
Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements.人类细胞中短端粒的融合表现为广泛的缺失和微同源性,可能导致复杂的重排。
Nucleic Acids Res. 2010 Apr;38(6):1841-52. doi: 10.1093/nar/gkp1183. Epub 2009 Dec 21.
8
Telomere diseases.端粒疾病
N Engl J Med. 2009 Dec 10;361(24):2353-65. doi: 10.1056/NEJMra0903373.
9
Telomeres and telomerase in cancer.端粒与端粒酶与癌症。
Carcinogenesis. 2010 Jan;31(1):9-18. doi: 10.1093/carcin/bgp268. Epub 2009 Nov 3.
10
Altered states of telomere deprotection and the two-stage mechanism of replicative aging.端粒去保护状态的改变与复制性衰老的两阶段机制。
Mol Cell Biol. 2009 May;29(9):2390-7. doi: 10.1128/MCB.01569-08. Epub 2009 Feb 17.

端粒融合在早期人类乳腺癌中。

Telomere fusions in early human breast carcinoma.

机构信息

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14098-103. doi: 10.1073/pnas.1120062109. Epub 2012 Aug 13.

DOI:10.1073/pnas.1120062109
PMID:22891313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3435165/
Abstract

Several lines of evidence suggest that defects in telomere maintenance play a significant role in the initiation of genomic instability during carcinogenesis. Although the general concept of defective telomere maintenance initiating genomic instability has been acknowledged, there remains a critical gap in the direct evidence of telomere dysfunction in human solid tumors. To address this topic, we devised a multiplex PCR-based assay, termed TAR (telomere-associated repeat) fusion PCR, to detect and analyze chromosome end-to-end associations (telomere fusions) within human breast tumor tissue. Using TAR fusion PCR, we found that human breast lesions, but not normal breast tissues from healthy volunteers, contained telomere fusions. Telomere fusions were detected at similar frequencies during early ductal carcinoma in situ and in the later invasive ductal carcinoma stage. Our results provide direct evidence that telomere fusions are present in human breast tumor tissue and suggest that telomere dysfunction may be an important component of the genomic instability observed in this cancer. Development of this robust method that allows identification of these genetic aberrations (telomere fusions) is anticipated to be a valuable tool for dissecting mechanisms of telomere dysfunction.

摘要

有几条证据表明,端粒维持缺陷在致癌过程中基因组不稳定性的起始中起着重要作用。尽管已经承认了端粒维持缺陷引发基因组不稳定性的一般概念,但在人类实体瘤中端粒功能障碍的直接证据方面仍然存在关键差距。为了解决这个问题,我们设计了一种基于多重 PCR 的检测方法,称为 TAR(端粒相关重复)融合 PCR,用于检测和分析人类乳腺肿瘤组织中的染色体端到端关联(端粒融合)。使用 TAR 融合 PCR,我们发现人类乳腺病变,而不是健康志愿者的正常乳腺组织,含有端粒融合。在早期导管原位癌和晚期浸润性导管癌阶段,端粒融合的检测频率相似。我们的结果提供了直接证据,证明端粒融合存在于人类乳腺肿瘤组织中,并表明端粒功能障碍可能是这种癌症中观察到的基因组不稳定性的一个重要组成部分。这种能够识别这些遗传异常(端粒融合)的强大方法的开发有望成为剖析端粒功能障碍机制的有用工具。